[{"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-001", "question": "A 68-year-old man with metastatic castration-resistant prostate cancer (mCRPC) on enzalutamide presents with progressive dyspnea and fatigue. He has no chest pain or fever. His oxygen saturation is 88% on room air. CT pulmonary angiography shows no pulmonary embolism, but reveals diffuse ground-glass opacities with peripheral sparing. Bronchoalveolar lavage shows lymphocytic predominance with CD4:CD8 ratio of 0.3. Which of the following is the most appropriate next step in management?", "options": ["Discontinue enzalutamide and initiate high-dose corticosteroids", "Initiate empiric broad-spectrum antibiotics for atypical pneumonia", "Add abiraterone to his current regimen and continue enzalutamide", "Perform transbronchial biopsy to rule out lymphangitic carcinomatosis", "Start therapeutic-dose low-molecular-weight heparin for occult pulmonary embolism"], "answer": "A", "answer_index": 0, "explanation": "This presentation is classic for enzalutamide-induced interstitial pneumonitis, which typically presents with subacute dyspnea, ground-glass opacities on CT, and a lymphocytic BAL with low CD4:CD8 ratio. Immediate discontinuation of the offending agent and initiation of corticosteroids is the standard management. Antibiotics are not indicated without infectious signs, and adding abiraterone would exacerbate the drug-induced lung injury.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Elderly man with metastatic castration‑resistant prostate cancer on enzalutamide; new subacute dyspnea and hypoxemia; CT shows diffuse ground‑glass opacities with peripheral sparing and no PE; BAL with lymphocytic predominance and low CD4:CD8 ratio (0.3); no fever or chest pain. These features support drug‑induced interstitial pneumonitis and argue against infection, PE, or tumor spread.\\nOption A (discontinue enzalutamide and initiate high‑dose corticosteroids) aligns with standard management of suspected drug‑induced interstitial lung disease when alternate causes are unlikely. B is worse: no infectious symptoms or imaging pattern typical for pneumonia. C is inappropriate escalation and continues potential culprit drug. D is lower yield and potentially risky; a biopsy is not required before stopping a likely offending agent when noninvasive data are supportive. E is contraindicated given negative CT for PE.\\nMain medical accuracy issues: Enzalutamide pneumonitis is rare but reported; description is plausible and management consistent with general drug‑induced ILD guidance. No major inaccuracies.\\nMinimal fix: Add a brief time course (e.g., “3 weeks of progressively worsening dyspnea”) to emphasize subacute onset typical of drug‑induced pneumonitis and further de‑emphasize acute infection/PE.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Elderly man with metastatic castration‑resistant prostate cancer on enzalutamide; new subacute dyspnea and hypoxemia; CT shows diffuse ground‑glass opacities with peripheral sparing and no PE; BAL with lymphocytic predominance and low CD4:CD8 ratio (0.3); no fever or chest pain. These features support drug‑induced interstitial pneumonitis and argue against infection, PE, or tumor spread.\nOption A (discontinue enzalutamide and initiate high‑dose corticosteroids) aligns with standard management of suspected drug‑induced interstitial lung disease when alternate causes are unlikely. B is worse: no infectious symptoms or imaging pattern typical for pneumonia. C is inappropriate escalation and continues potential culprit drug. D is lower yield and potentially risky; a biopsy is not required before stopping a likely offending agent when noninvasive data are supportive. E is contraindicated given negative CT for PE.\nMain medical accuracy issues: Enzalutamide pneumonitis is rare but reported; description is plausible and management consistent with general drug‑induced ILD guidance. No major inaccuracies.\nMinimal fix: Add a brief time course (e.g., “3 weeks of progressively worsening dyspnea”) to emphasize subacute onset typical of drug‑induced pneumonitis and further de‑emphasize acute infection/PE.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-002", "question": "A 4-month-old previously healthy infant presents with acute onset of irritability, vomiting, and lethargy. Physical examination reveals a bulging anterior fontanelle, retinal hemorrhages, and no focal neurologic deficits. Non-contrast head CT shows bilateral subdural hematomas of different ages. The infant's coagulation studies and metabolic panel are normal. Which of the following additional findings would most strongly support a diagnosis of glutaric aciduria type 1 rather than non-accidental trauma?", "options": ["Metaphyseal corner fractures on skeletal survey", "Elevated serum ammonia level", "Frontotemporal atrophy with widened Sylvian fissures on MRI", "Subarachnoid hemorrhage extending into the posterior fossa", "Elevated urine organic acids showing 3-hydroxyglutaric aciduria"], "answer": "E", "answer_index": 4, "explanation": "While glutaric aciduria type 1 can mimic non-accidental trauma with acute encephalopathy and subdural hematomas, the definitive diagnosis requires demonstration of elevated urine organic acids, specifically 3-hydroxyglutaric aciduria. Frontotemporal atrophy (option C) is a characteristic neuroimaging finding but is not diagnostic. Metaphyseal fractures strongly suggest abuse, while elevated ammonia suggests a different metabolic disorder.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 4‑month-old with acute irritability, vomiting, lethargy; bulging fontanelle; retinal hemorrhages; bilateral subdural hematomas of different ages; normal coagulation and metabolic panel; question asks what would most strongly support glutaric aciduria type I (GA1) rather than non-accidental trauma.\\nGA1 is an organic acidemia due to glutaryl-CoA dehydrogenase deficiency; definitive diagnosis relies on characteristic organic acid profile (notably elevated 3‑hydroxyglutaric acid) in urine or confirmatory enzyme/genetic testing. Option E (elevated urine organic acids showing 3‑hydroxyglutaric aciduria) is therefore clearly the strongest, most specific evidence for GA1.\\nOption C (frontotemporal atrophy with widened Sylvian fissures) is indeed a recognized and supportive neuroimaging feature in GA1, but is not diagnostic and can be less specific; the stem and explanation correctly note this hierarchy, so E > C. Options A and D are either more suggestive of trauma or nonspecific; B indicates another type of metabolic disorder.\\nNo internal contradictions or underspecification are apparent; single best answer exists and matches key. Medical content is up-to-date and accurate for board level.\\nMinimal fix: Add that enzyme or genetic testing could also confirm GA1, to emphasize E as biochemical diagnostic evidence rather than the sole definitive test.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 4‑month-old with acute irritability, vomiting, lethargy; bulging fontanelle; retinal hemorrhages; bilateral subdural hematomas of different ages; normal coagulation and metabolic panel; question asks what would most strongly support glutaric aciduria type I (GA1) rather than non-accidental trauma.\nGA1 is an organic acidemia due to glutaryl-CoA dehydrogenase deficiency; definitive diagnosis relies on characteristic organic acid profile (notably elevated 3‑hydroxyglutaric acid) in urine or confirmatory enzyme/genetic testing. Option E (elevated urine organic acids showing 3‑hydroxyglutaric aciduria) is therefore clearly the strongest, most specific evidence for GA1.\nOption C (frontotemporal atrophy with widened Sylvian fissures) is indeed a recognized and supportive neuroimaging feature in GA1, but is not diagnostic and can be less specific; the stem and explanation correctly note this hierarchy, so E > C. Options A and D are either more suggestive of trauma or nonspecific; B indicates another type of metabolic disorder.\nNo internal contradictions or underspecification are apparent; single best answer exists and matches key. Medical content is up-to-date and accurate for board level.\nMinimal fix: Add that enzyme or genetic testing could also confirm GA1, to emphasize E as biochemical diagnostic evidence rather than the sole definitive test.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-003", "question": "A 55-year-old woman with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) who failed CAR T-cell therapy 3 months ago presents with new-onset confusion and myoclonus. MRI brain shows symmetric diffusion restriction in the bilateral thalami, basal ganglia, and cerebral cortex. EEG demonstrates periodic sharp wave complexes. CSF shows 12 white cells/mm³ (90% lymphocytes), normal glucose, and elevated protein at 80 mg/dL. Which of the following is the most likely causative agent?", "options": ["Tafasitamab", "Polatuzumab vedotin", "Tisagenlecleucel", "Blinatumomab", "Brentuximab vedotin"], "answer": "C", "answer_index": 2, "explanation": "This presentation is classic for CAR T-cell therapy-related immune effector cell-associated neurotoxicity syndrome (ICANS), which can occur weeks to months after treatment. The MRI pattern of symmetric deep gray matter and cortical involvement with corresponding EEG findings is characteristic. Tisagenlecleucel is a CD19-directed CAR T-cell therapy used in DLBCL. The other agents are monoclonal antibodies or antibody-drug conjugates not typically associated with this specific delayed neurotoxicity pattern.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (Miskeyed)\\nVerdict on keyed answer: Miskeyed — C is not the best answer\\nKey stem clues: 55-year-old with relapsed/refractory DLBCL; **failed CAR T-cell therapy 3 months ago**; now new confusion and myoclonus; MRI with symmetric thalamic/basal ganglia/cortical diffusion restriction; EEG with periodic sharp wave complexes; mild lymphocytic CSF with ↑protein. These features (deep gray matter involvement, periodic sharp waves) are classic for **prion disease (Creutzfeldt–Jakob disease)**, not ICANS. ICANS typically occurs days–few weeks after CAR T infusion, is largely reversible, and does not have a stereotyped CJD-like MRI/EEG pattern. The question asks for the “most likely causative agent” and all choices are drugs, but none are known causes of CJD; CAR T exposure 3 months earlier is at best a weak association and not established causation.\\nMain logical issue(s): The diagnosis implied by the data (CJD) does not align with the explanation (ICANS); thus no option is clearly correct, and choosing Tisagenlecleucel requires ignoring the imaging/EEG pattern and timing.\\nMain medical accuracy issue(s): Mischaracterization of these findings as “classic” for ICANS.\\nMinimal fix: Change the MRI/EEG/CSF findings and timing to a typical acute ICANS picture (e.g., nonspecific T2/FLAIR changes, diffuse slowing on EEG, occurring within 1–4 weeks post–CAR T).\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed)\nVerdict on keyed answer: Miskeyed — C is not the best answer\nKey stem clues: 55-year-old with relapsed/refractory DLBCL; **failed CAR T-cell therapy 3 months ago**; now new confusion and myoclonus; MRI with symmetric thalamic/basal ganglia/cortical diffusion restriction; EEG with periodic sharp wave complexes; mild lymphocytic CSF with ↑protein. These features (deep gray matter involvement, periodic sharp waves) are classic for **prion disease (Creutzfeldt–Jakob disease)**, not ICANS. ICANS typically occurs days–few weeks after CAR T infusion, is largely reversible, and does not have a stereotyped CJD-like MRI/EEG pattern. The question asks for the “most likely causative agent” and all choices are drugs, but none are known causes of CJD; CAR T exposure 3 months earlier is at best a weak association and not established causation.\nMain logical issue(s): The diagnosis implied by the data (CJD) does not align with the explanation (ICANS); thus no option is clearly correct, and choosing Tisagenlecleucel requires ignoring the imaging/EEG pattern and timing.\nMain medical accuracy issue(s): Mischaracterization of these findings as “classic” for ICANS.\nMinimal fix: Change the MRI/EEG/CSF findings and timing to a typical acute ICANS picture (e.g., nonspecific T2/FLAIR changes, diffuse slowing on EEG, occurring within 1–4 weeks post–CAR T).", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-004", "question": "A critically ill patient with septic shock on norepinephrine (0.3 mcg/kg/min) and vasopressin (0.03 units/min) develops refractory hypotension. Transthoracic echocardiogram shows a hyperdynamic left ventricle with collapsing mitral inflow pattern. Which of the following interventions is most likely to improve hemodynamics without increasing myocardial oxygen demand?", "options": ["Initiate dobutamine infusion at 5 mcg/kg/min", "Add phenylephrine infusion to target MAP >65 mmHg", "Administer 500 mL 5% albumin bolus", "Start angiotensin II infusion at 20 ng/kg/min", "Increase norepinephrine to 0.5 mcg/kg/min"], "answer": "D", "answer_index": 3, "explanation": "The echocardiographic findings suggest distributive shock with relative hypovolemia. Angiotensin II acts via AT1 receptors to cause vasoconstriction without significant inotropic effects, making it ideal for this scenario without increasing myocardial oxygen demand. Dobutamine increases myocardial demand, phenylephrine causes pure alpha-agonism with potential reflex bradycardia, fluid bolus may be insufficient in vasoplegic shock, and increasing norepinephrine adds beta-1 effects that increase oxygen consumption.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Critically ill patient with septic shock already on high-dose norepinephrine (0.3 mcg/kg/min) and vasopressin (0.03 units/min) who develops refractory hypotension; TTE shows hyperdynamic LV with collapsing mitral inflow, consistent with distributive/vasoplegic shock and preserved/augmented contractility rather than cardiogenic failure. Question asks for an intervention to improve hemodynamics without increasing myocardial oxygen demand.\\nAngiotensin II (D) is an appropriate third-line vasopressor in catecholamine-refractory vasodilatory shock; its primary AT1-mediated vasoconstriction has minimal direct inotropic effect and comparatively less increase in myocardial oxygen demand than further catecholamine or inotrope escalation. A (dobutamine) and E (more norepinephrine) both increase beta-1 stimulation and myocardial O2 consumption. B (phenylephrine) is a pure alpha-agonist and could be considered, but it is not standard as an add-on in septic shock compared with angiotensin II and does not address catecholamine-refractoriness as well; angiotensin II has specific evidence in this setting. C (albumin bolus) may help if truly hypovolemic, but TTE suggests primarily vasodilatory physiology rather than volume depletion, and additional fluid poses risk without clear benefit.\\nMinimal fix: Clarify that the patient is adequately fluid resuscitated to further justify avoiding option C and strengthen uniqueness of D.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Critically ill patient with septic shock already on high-dose norepinephrine (0.3 mcg/kg/min) and vasopressin (0.03 units/min) who develops refractory hypotension; TTE shows hyperdynamic LV with collapsing mitral inflow, consistent with distributive/vasoplegic shock and preserved/augmented contractility rather than cardiogenic failure. Question asks for an intervention to improve hemodynamics without increasing myocardial oxygen demand.\nAngiotensin II (D) is an appropriate third-line vasopressor in catecholamine-refractory vasodilatory shock; its primary AT1-mediated vasoconstriction has minimal direct inotropic effect and comparatively less increase in myocardial oxygen demand than further catecholamine or inotrope escalation. A (dobutamine) and E (more norepinephrine) both increase beta-1 stimulation and myocardial O2 consumption. B (phenylephrine) is a pure alpha-agonist and could be considered, but it is not standard as an add-on in septic shock compared with angiotensin II and does not address catecholamine-refractoriness as well; angiotensin II has specific evidence in this setting. C (albumin bolus) may help if truly hypovolemic, but TTE suggests primarily vasodilatory physiology rather than volume depletion, and additional fluid poses risk without clear benefit.\nMinimal fix: Clarify that the patient is adequately fluid resuscitated to further justify avoiding option C and strengthen uniqueness of D.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-005", "question": "A 7-year-old boy presents with acute cerebellar ataxia following varicella infection 2 weeks prior. MRI shows T2 hyperintensity restricted to the cerebellar hemispheres. CSF demonstrates 15 lymphocytes/mm³, normal glucose, and elevated IgG index. Which of the following autoantibodies is most specific for this condition?", "options": ["Anti-GAD65", "Anti-Hu", "Anti-Yo", "Anti-Tr/DNER", "Anti-mGluR1"], "answer": "D", "answer_index": 3, "explanation": "Post-varicella acute cerebellar ataxia is associated with anti-Tr/DNER (delta/notch-like epidermal growth factor-related receptor) antibodies in a significant proportion of cases. This antibody is highly specific for paraneoplastic cerebellar degeneration in Hodgkin lymphoma but also occurs in post-infectious contexts. Anti-Yo and anti-Hu are associated with gynecological/breast cancers and small cell lung cancer respectively. Anti-mGluR1 is seen in Hodgkin-related ataxia, while anti-GAD65 is associated with stiff-person syndrome.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (miskeyed)\\nVerdict on keyed answer: Miskeyed – the best-supported answer is E (anti-mGluR1), not D.\\n\\nKey stem clues: 7-year-old boy; acute post-varicella cerebellar ataxia (2 weeks after infection); MRI with isolated cerebellar T2 hyperintensity; CSF with mild lymphocytic pleocytosis and elevated IgG index, compatible with post-infectious autoimmune cerebellitis rather than classic paraneoplastic cerebellar degeneration.\\n\\nMain logical/medical issue: Anti-Tr/DNER antibodies are classically and highly specific for paraneoplastic cerebellar degeneration in Hodgkin lymphoma, typically in adults. The stem gives no suggestion of malignancy; it describes a classic monophasic post-varicella cerebellar ataxia in a child. By contrast, anti-mGluR1 antibodies are the principal autoantibody reported in Hodgkin-related or post-infectious cerebellar ataxia syndromes. The provided explanation even states “Anti-mGluR1 is seen in Hodgkin-related ataxia,” undermining choice D as “most specific” for the described non-paraneoplastic, post-varicella setting.\\n\\nMinimal fix: Either (1) change the question to ask for the autoantibody most specific for Hodgkin-associated paraneoplastic cerebellar degeneration (then D would be correct), or (2) change the keyed answer to E (anti-mGluR1) and adjust the explanation accordingly.\\n\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (miskeyed)\nVerdict on keyed answer: Miskeyed – the best-supported answer is E (anti-mGluR1), not D.\n\nKey stem clues: 7-year-old boy; acute post-varicella cerebellar ataxia (2 weeks after infection); MRI with isolated cerebellar T2 hyperintensity; CSF with mild lymphocytic pleocytosis and elevated IgG index, compatible with post-infectious autoimmune cerebellitis rather than classic paraneoplastic cerebellar degeneration.\n\nMain logical/medical issue: Anti-Tr/DNER antibodies are classically and highly specific for paraneoplastic cerebellar degeneration in Hodgkin lymphoma, typically in adults. The stem gives no suggestion of malignancy; it describes a classic monophasic post-varicella cerebellar ataxia in a child. By contrast, anti-mGluR1 antibodies are the principal autoantibody reported in Hodgkin-related or post-infectious cerebellar ataxia syndromes. The provided explanation even states “Anti-mGluR1 is seen in Hodgkin-related ataxia,” undermining choice D as “most specific” for the described non-paraneoplastic, post-varicella setting.\n\nMinimal fix: Either (1) change the question to ask for the autoantibody most specific for Hodgkin-associated paraneoplastic cerebellar degeneration (then D would be correct), or (2) change the keyed answer to E (anti-mGluR1) and adjust the explanation accordingly.\n", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-006", "question": "A 42-year-old woman with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) achieves complete morphological remission after induction chemotherapy. Minimal residual disease (MRD) testing by flow cytometry shows 0.01% blasts. Which of the following factors would most strongly indicate proceeding to allogeneic hematopoietic stem cell transplantation in first complete remission rather than continuing with chemotherapy plus a tyrosine kinase inhibitor?", "options": ["Presence of IKZF1 deletion", "Age >40 years", "MRD positivity after consolidation therapy", "White blood cell count >30,000/μL at diagnosis", "Presence of additional cytogenetic abnormalities besides t(9;22)"], "answer": "C", "answer_index": 2, "explanation": "In Ph+ ALL, MRD positivity after consolidation therapy is the strongest predictor of poor outcome with chemotherapy/TKI alone and is a clear indication for allogeneic transplantation in first remission. While age >40, high WBC, IKZF1 deletion, and additional abnormalities are adverse prognostic factors, contemporary TKI-based regimens can overcome many of these. Persistent MRD after intensive therapy indicates resistant disease requiring transplant for cure.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Ph+ ALL; patient in morphological CR after induction; MRD by flow = 0.01% (positive); question asks which factor would most strongly indicate proceeding to allogeneic HSCT in first CR rather than continuing chemotherapy + TKI.\\nThe central clinical concept is that, in modern Ph+ ALL management, post-treatment MRD status is the strongest prognostic marker and principal driver for HSCT decision-making. Among the options, only C (MRD positivity after consolidation) represents a dynamic, treatment-response–based risk factor clearly associated with poor outcomes on chemo/TKI alone and widely used as a clear indication for transplant in first CR.\\nOther options (age >40, high initial WBC, IKZF1 deletion, additional cytogenetic abnormalities) are baseline adverse features, but current TKI-based regimens can mitigate their impact; they do not on their own mandate HSCT if deep MRD negativity is achieved. Thus, C is uniquely best and matches the key.\\nMedical accuracy is strong and reflects contemporary risk-adapted, MRD-guided strategy in Ph+ ALL.\\nMinimal fix: Explicitly state that after consolidation the patient’s MRD remains detectable, to align stem temporally with option C and avoid any ambiguity about MRD time point.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Ph+ ALL; patient in morphological CR after induction; MRD by flow = 0.01% (positive); question asks which factor would most strongly indicate proceeding to allogeneic HSCT in first CR rather than continuing chemotherapy + TKI.\nThe central clinical concept is that, in modern Ph+ ALL management, post-treatment MRD status is the strongest prognostic marker and principal driver for HSCT decision-making. Among the options, only C (MRD positivity after consolidation) represents a dynamic, treatment-response–based risk factor clearly associated with poor outcomes on chemo/TKI alone and widely used as a clear indication for transplant in first CR.\nOther options (age >40, high initial WBC, IKZF1 deletion, additional cytogenetic abnormalities) are baseline adverse features, but current TKI-based regimens can mitigate their impact; they do not on their own mandate HSCT if deep MRD negativity is achieved. Thus, C is uniquely best and matches the key.\nMedical accuracy is strong and reflects contemporary risk-adapted, MRD-guided strategy in Ph+ ALL.\nMinimal fix: Explicitly state that after consolidation the patient’s MRD remains detectable, to align stem temporally with option C and avoid any ambiguity about MRD time point.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-007", "question": "A 65-year-old man with atrial fibrillation on apixaban presents with acute onset of aphasia and right hemiparesis. CT head shows a 3 cm left MCA territory infarct with no hemorrhage. Last apixaban dose was 4 hours ago. NIH Stroke Scale is 18. Which of the following is the most appropriate acute intervention?", "options": ["Administer intravenous tissue plasminogen activator immediately", "Give 4-factor prothrombin complex concentrate followed by tPA", "Perform emergent mechanical thrombectomy without thrombolysis", "Administer andexanet alfa followed by mechanical thrombectomy", "Give idarucizumab empirically followed by mechanical thrombectomy"], "answer": "C", "answer_index": 2, "explanation": "For large vessel occlusion strokes in patients on direct oral anticoagulants (DOACs) with recent dosing, mechanical thrombectomy without thrombolysis is recommended due to the increased risk of hemorrhagic transformation with tPA. Andexanet alfa is a reversal agent for factor Xa inhibitors but is not routinely recommended prior to thrombectomy unless there is life-threatening bleeding. Idarucizumab is for dabigatran reversal. PCC before tPA still carries bleeding risk and delays intervention.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: 65-year-old man, acute focal deficits (aphasia, right hemiparesis), NIHSS 18 (severe stroke), CT shows 3 cm left MCA territory infarct without hemorrhage, atrial fibrillation on apixaban with last dose 4 hours ago (therapeutic factor Xa inhibitor in system). This is highly suggestive of an acute large-vessel occlusion, in a patient on a DOAC within the last 48 hours, which is generally considered a contraindication to IV alteplase in standard guideline-based practice when drug activity is presumed present.\\n\\nMost appropriate acute intervention is emergent mechanical thrombectomy without thrombolysis (C); this directly treats a likely large-vessel occlusion and avoids tPA in the context of recent apixaban use. A and B involve IV thrombolysis in a patient on a recent DOAC and are guideline-incongruent and higher risk. D introduces andexanet alfa without indication for reversal (no life-threatening bleeding), not a standard pre-thrombectomy requirement. E uses idarucizumab, which reverses dabigatran, not apixaban.\\n\\nMinimal fix: Explicitly state CT angiography has confirmed a proximal left MCA large-vessel occlusion to align more tightly with standard thrombectomy indications and reduce any ambiguity.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: 65-year-old man, acute focal deficits (aphasia, right hemiparesis), NIHSS 18 (severe stroke), CT shows 3 cm left MCA territory infarct without hemorrhage, atrial fibrillation on apixaban with last dose 4 hours ago (therapeutic factor Xa inhibitor in system). This is highly suggestive of an acute large-vessel occlusion, in a patient on a DOAC within the last 48 hours, which is generally considered a contraindication to IV alteplase in standard guideline-based practice when drug activity is presumed present.\n\nMost appropriate acute intervention is emergent mechanical thrombectomy without thrombolysis (C); this directly treats a likely large-vessel occlusion and avoids tPA in the context of recent apixaban use. A and B involve IV thrombolysis in a patient on a recent DOAC and are guideline-incongruent and higher risk. D introduces andexanet alfa without indication for reversal (no life-threatening bleeding), not a standard pre-thrombectomy requirement. E uses idarucizumab, which reverses dabigatran, not apixaban.\n\nMinimal fix: Explicitly state CT angiography has confirmed a proximal left MCA large-vessel occlusion to align more tightly with standard thrombectomy indications and reduce any ambiguity.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-008", "question": "A 3-year-old child with DiGeorge syndrome (22q11.2 deletion) presents with hypocalcemic seizures. Correction of calcium with intravenous calcium gluconate and calcitriol is initiated. Which of the following immunologic parameters, if present, would be an absolute contraindication to live viral vaccination?", "options": ["CD4+ T cell count <500 cells/μL", "Absent thymic shadow on chest radiograph", "Low but detectable T cell receptor excision circles (TRECs)", "Severely reduced proliferative response to phytohemagglutinin", "Complete absence of CD3+ T cells by flow cytometry"], "answer": "E", "answer_index": 4, "explanation": "Complete absence of CD3+ T cells indicates severe combined immunodeficiency (SCID) phenotype within DiGeorge spectrum, which is an absolute contraindication to live vaccines due to risk of disseminated infection. Reduced proliferative responses (option D) indicate functional impairment but not complete absence. Low TRECs suggest poor thymic output but not necessarily SCID. CD4 count and thymic shadow are not definitive contraindications alone.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Child with DiGeorge syndrome (22q11.2 deletion), concern is safety of live viral vaccines in the context of T‑cell immunodeficiency. The question asks for an *absolute* contraindication, i.e., severe cellular immunodeficiency comparable to SCID.\\nOption E (complete absence of CD3+ T cells) best represents a SCID-like phenotype, for which live viral vaccines are absolutely contraindicated. This aligns with ACIP/CDC and standard immunology guidance.\\nOption A (CD4 <500/µL) is immunocompromised but not in itself an absolute contraindication without broader context; pediatric oncology/HIV patients sometimes safely receive selected live vaccines above much lower thresholds. Option B (absent thymic shadow) is suggestive of thymic aplasia but radiographic finding alone is not a formal vaccine-eligibility criterion. Option C (low but detectable TRECs) and option D (severely reduced proliferative response) show impaired but not absent T‑cell function and are not automatically absolute contraindications; decisions there are individualized.\\nNo internal contradictions or underspecification; single clearly superior answer consistent with the rationale.\\nMinimal fix: Add “per current ACIP guidance” or “per standard live viral vaccine contraindication criteria” to the stem to anchor the standard being tested.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Child with DiGeorge syndrome (22q11.2 deletion), concern is safety of live viral vaccines in the context of T‑cell immunodeficiency. The question asks for an *absolute* contraindication, i.e., severe cellular immunodeficiency comparable to SCID.\nOption E (complete absence of CD3+ T cells) best represents a SCID-like phenotype, for which live viral vaccines are absolutely contraindicated. This aligns with ACIP/CDC and standard immunology guidance.\nOption A (CD4 <500/µL) is immunocompromised but not in itself an absolute contraindication without broader context; pediatric oncology/HIV patients sometimes safely receive selected live vaccines above much lower thresholds. Option B (absent thymic shadow) is suggestive of thymic aplasia but radiographic finding alone is not a formal vaccine-eligibility criterion. Option C (low but detectable TRECs) and option D (severely reduced proliferative response) show impaired but not absent T‑cell function and are not automatically absolute contraindications; decisions there are individualized.\nNo internal contradictions or underspecification; single clearly superior answer consistent with the rationale.\nMinimal fix: Add “per current ACIP guidance” or “per standard live viral vaccine contraindication criteria” to the stem to anchor the standard being tested.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-009", "question": "A patient with glioblastoma on temozolomide and dexamethasone develops progressive headache, visual changes, and diabetes insipidus. MRI shows thickening and enhancement of the pituitary stalk with loss of the posterior pituitary bright spot. CSF cytology is negative. Which of the following findings would most strongly support a diagnosis of lymphocytic hypophysitis over pituitary metastasis?", "options": ["Presence of anti-pituitary antibodies", "Elevated CSF beta-2 transferrin", "Simultaneous involvement of the pineal gland", "Rapid improvement with high-dose corticosteroids", "Association with other autoimmune endocrine deficiencies"], "answer": "E", "answer_index": 4, "explanation": "Lymphocytic hypophysitis frequently presents with other autoimmune endocrine deficiencies (thyroiditis, adrenalitis, diabetes mellitus type 1), while pituitary metastases typically occur in isolation. Anti-pituitary antibodies have poor sensitivity/specificity. CSF beta-2 transferrin indicates CSF leak. Pineal involvement suggests germinoma. Steroid responsiveness occurs in both conditions but is more dramatic in hypophysitis; however, association with other autoimmune conditions is more specific.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: Known systemic malignancy (glioblastoma) on temozolomide and dexamethasone; new stalk thickening and enhancement with DI raises the differential of lymphocytic hypophysitis vs pituitary metastasis. Question asks for the finding most strongly supporting lymphocytic hypophysitis over metastasis.\\n\\nChoice E (association with other autoimmune endocrine deficiencies) is a classic feature of lymphocytic hypophysitis and has relatively high specificity compared with pituitary metastasis, which usually lacks systemic autoimmune endocrine disease. That makes E the best discriminator.\\n\\nA: Anti‑pituitary antibodies are neither sensitive nor specific and can be present in other pituitary conditions; the stem’s own explanation notes this limitation. B: CSF β2‑transferrin simply indicates a CSF leak and is unrelated to distinguishing these two entities. C: Pineal involvement suggests germinoma, not hypophysitis vs metastasis. D: Both hypophysitis and metastasis may show steroid responsiveness (metastasis via edema reduction); this is therefore less specific than E.\\n\\nNo internal contradictions or missing critical data; one clearly superior option exists and matches the key.\\n\\nMinimal fix: Clarify in the stem that the question is about “the most specific distinguishing feature” to align wording tightly with the teaching point already implied in the explanation.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: Known systemic malignancy (glioblastoma) on temozolomide and dexamethasone; new stalk thickening and enhancement with DI raises the differential of lymphocytic hypophysitis vs pituitary metastasis. Question asks for the finding most strongly supporting lymphocytic hypophysitis over metastasis.\n\nChoice E (association with other autoimmune endocrine deficiencies) is a classic feature of lymphocytic hypophysitis and has relatively high specificity compared with pituitary metastasis, which usually lacks systemic autoimmune endocrine disease. That makes E the best discriminator.\n\nA: Anti‑pituitary antibodies are neither sensitive nor specific and can be present in other pituitary conditions; the stem’s own explanation notes this limitation. B: CSF β2‑transferrin simply indicates a CSF leak and is unrelated to distinguishing these two entities. C: Pineal involvement suggests germinoma, not hypophysitis vs metastasis. D: Both hypophysitis and metastasis may show steroid responsiveness (metastasis via edema reduction); this is therefore less specific than E.\n\nNo internal contradictions or missing critical data; one clearly superior option exists and matches the key.\n\nMinimal fix: Clarify in the stem that the question is about “the most specific distinguishing feature” to align wording tightly with the teaching point already implied in the explanation.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-010", "question": "A neonate born at 32 weeks gestation develops necrotizing enterocolitis (NEC) on day 10 of life. During laparotomy, approximately 40% of the small bowel appears necrotic. Which of the following intraoperative findings would mandate creation of a high jejunostomy rather than primary anastomosis?", "options": ["Involvement of the ileocecal valve", "Necrosis extending to within 5 cm of the ligament of Treitz", "Presence of pneumatosis intestinalis in the remaining bowel", "Concurrent isolated perforation of the gastric fundus", "Development of abdominal compartment syndrome during surgery"], "answer": "B", "answer_index": 1, "explanation": "Necrosis extending to within 5 cm of the ligament of Treitz indicates near-total small bowel loss, requiring high jejunostomy to preserve the maximal possible length of viable bowel for future adaptation and prevent anastomotic leakage in compromised tissue. Ileocecal valve involvement is important for absorption but doesn't dictate anastomosis vs ostomy. Pneumatosis may be present in non-necrotic bowel. Gastric perforation is managed separately. Abdominal compartment syndrome may require temporary closure but not necessarily jejunostomy.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 32‑week premature neonate with NEC, 40% small bowel necrotic at laparotomy; question asks which intraoperative finding would *mandate* a high jejunostomy instead of primary anastomosis. The key concept is inadequate length/quality of remaining proximal small bowel for a safe anastomosis.\\nChoice B (necrosis to within 5 cm of the ligament of Treitz) implies only a very short segment of proximal jejunum remains; in NEC, this high-risk situation generally requires creation of a proximal jejunostomy to preserve maximal length and avoid a tenuous duodenojejunal anastomosis in edematous, inflamed bowel.\\nOther options: A) Ileocecal valve loss worsens functional outcome but does not itself mandate ostomy over anastomosis if adequate healthy bowel exists. C) Pneumatosis in remaining bowel can be reversible and does not necessarily preclude primary anastomosis if tissue is viable. D) Isolated gastric perforation is treated separately and doesn’t dictate small-bowel reconstruction choice. E) Abdominal compartment syndrome influences closure strategy, not specifically need for high jejunostomy.\\nMain medical accuracy issues: None significant; explanations are consistent with pediatric surgery principles.\\nMinimal fix: Explicitly state that the remaining proximal bowel segment is extremely short and edematous to more clearly justify jejunostomy over primary anastomosis.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 32‑week premature neonate with NEC, 40% small bowel necrotic at laparotomy; question asks which intraoperative finding would *mandate* a high jejunostomy instead of primary anastomosis. The key concept is inadequate length/quality of remaining proximal small bowel for a safe anastomosis.\nChoice B (necrosis to within 5 cm of the ligament of Treitz) implies only a very short segment of proximal jejunum remains; in NEC, this high-risk situation generally requires creation of a proximal jejunostomy to preserve maximal length and avoid a tenuous duodenojejunal anastomosis in edematous, inflamed bowel.\nOther options: A) Ileocecal valve loss worsens functional outcome but does not itself mandate ostomy over anastomosis if adequate healthy bowel exists. C) Pneumatosis in remaining bowel can be reversible and does not necessarily preclude primary anastomosis if tissue is viable. D) Isolated gastric perforation is treated separately and doesn’t dictate small-bowel reconstruction choice. E) Abdominal compartment syndrome influences closure strategy, not specifically need for high jejunostomy.\nMain medical accuracy issues: None significant; explanations are consistent with pediatric surgery principles.\nMinimal fix: Explicitly state that the remaining proximal bowel segment is extremely short and edematous to more clearly justify jejunostomy over primary anastomosis.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]